Immix Biopharma Inc.

1.75
0.17 (10.76%)
At close: Feb 28, 2025, 3:59 PM
1.73
-0.98%
After-hours: Feb 28, 2025, 05:18 PM EST

Immix Biopharma Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 17.51M 13.44M 17.64M 391.09K 734.01K
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 87.23K 6.72K -0.00 -0.00 -0.00
Receivables 1.17M 255.71K 25.72K 127.44K 175.75K
Inventory n/a n/a n/a n/a n/a
Other Current Assets 1.11M 1.21M 516.19K 13.71K 23.5K
Total Current Assets 19.79M 14.9M 18.19M 532.24K 933.26K
Property-Plant & Equipment 50.18K 3.56K 5.7K 7.36K 9.68K
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 137.41K 10.28K 5.7K 7.36K 9.68K
Total Assets 19.93M 14.91M 18.19M 539.6K 942.94K
Account Payables 1.43M 143.07K 142.94K 252.34K 247.54K
Deferred Revenue n/a n/a n/a 342.84K n/a
Short-Term Debt n/a n/a 50K 4.1M 4.1M
Other Current Liabilities 2.29M 1.13M 9.1K 917.84K 241.76K
Total Current Liabilities 3.72M 1.27M 202.04K 5.27M 4.59M
Long-Term Debt n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a 475K n/a n/a n/a
Total Long-Term Liabilities n/a 475K n/a n/a n/a
Total Liabilities 3.72M 1.75M 202.04K 5.27M 4.59M
Total Debt n/a n/a 50K 4.1M 4.1M
Common Stock 2K 1.4K 1.32K 338.00 338.00
Retained Earnings -53.41M -37.99M -29.76M -5.37M -4.22M
Comprehensive Income 134.67K 87.02K 125.41K 131.86K 68.22K
Shareholders Equity 16.41M 13.16M 17.99M -4.73M -3.65M
Total Investments n/a n/a n/a n/a n/a